These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38341129)

  • 1. Assessing Physicochemical Stability of Monoclonal Antibodies in a Simulated Subcutaneous Environment.
    Jogdeo CM; Bhattacharya DS; Lin V; Kolhe P; Badkar A
    J Pharm Sci; 2024 Jul; 113(7):1854-1864. PubMed ID: 38341129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel in vitro method to model the fate of subcutaneously administered biopharmaceuticals and associated formulation components.
    Kinnunen HM; Sharma V; Contreras-Rojas LR; Yu Y; Alleman C; Sreedhara A; Fischer S; Khawli L; Yohe ST; Bumbaca D; Patapoff TW; Daugherty AL; Mrsny RJ
    J Control Release; 2015 Sep; 214():94-102. PubMed ID: 26210441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro model for predicting bioavailability of subcutaneously injected monoclonal antibodies.
    Bown HK; Bonn C; Yohe S; Yadav DB; Patapoff TW; Daugherty A; Mrsny RJ
    J Control Release; 2018 Mar; 273():13-20. PubMed ID: 29355621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of monoclonal antibodies after simulated subcutaneous administration.
    Schuster J; Mahler HC; Joerg S; Kamuju V; Huwyler J; Mathaes R
    J Pharm Sci; 2021 Jun; 110(6):2386-2394. PubMed ID: 33722546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of physiochemical properties on the subcutaneous absorption and bioavailability of monoclonal antibodies.
    Datta-Mannan A; Estwick S; Zhou C; Choi H; Douglass NE; Witcher DR; Lu J; Beidler C; Millican R
    MAbs; 2020 Jan; 12(1):1770028. PubMed ID: 32486889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicochemical Stability of Monoclonal Antibodies: A Review.
    Le Basle Y; Chennell P; Tokhadze N; Astier A; Sautou V
    J Pharm Sci; 2020 Jan; 109(1):169-190. PubMed ID: 31465737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous delivery of monoclonal antibodies: How do we get there?
    Viola M; Sequeira J; Seiça R; Veiga F; Serra J; Santos AC; Ribeiro AJ
    J Control Release; 2018 Sep; 286():301-314. PubMed ID: 30077735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the outcomes of biopharmaceutical delivery via the subcutaneous route by understanding the chemical, physical and physiological properties of the subcutaneous injection site.
    Kinnunen HM; Mrsny RJ
    J Control Release; 2014 May; 182():22-32. PubMed ID: 24631859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray drying: Models and pitfalls.
    Batens M; Massant J; Teodorescu B; Van den Mooter G
    Eur J Pharm Biopharm; 2018 Jun; 127():407-422. PubMed ID: 29499299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Monoclonal Antibody Disposition after Subcutaneous Administration using a Minimal Physiologically based Pharmacokinetic Model.
    Varkhede N; Forrest ML
    J Pharm Pharm Sci; 2018; 21(1s):130s-148s. PubMed ID: 30011390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A compartment model for subcutaneous injection of monoclonal antibodies.
    Zhong X; Liu Y; Ardekani AM
    Int J Pharm; 2024 Jan; 650():123687. PubMed ID: 38103705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen-deuterium exchange mass spectrometry as an emerging analytical tool for stabilization and formulation development of therapeutic monoclonal antibodies.
    Majumdar R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2015 Feb; 104(2):327-45. PubMed ID: 25354868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo Stability of Therapeutic Proteins.
    Schuster J; Koulov A; Mahler HC; Detampel P; Huwyler J; Singh S; Mathaes R
    Pharm Res; 2020 Jan; 37(2):23. PubMed ID: 31900680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Affinity-Capture Self-Interaction Nanoparticle Spectroscopy in Predicting Protein Stability, Especially for Co-Formulated Antibodies.
    Zhou M; Yan Z; Li H; Liu X; Sun P
    Pharm Res; 2021 Apr; 38(4):721-732. PubMed ID: 33754257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review.
    Matucci A; Vultaggio A; Danesi R
    Respir Res; 2018 Aug; 19(1):154. PubMed ID: 30115042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How spray drying processing and solution composition can affect the mAbs stability in reconstituted solutions for subcutaneous injections. Part II: Exploring each protein stabilizer effect.
    Barcelo-Chong CM; Filipe V; Nakach M; Inês Ré M
    Int J Pharm; 2024 Apr; 655():124014. PubMed ID: 38513817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How spray drying processing and solution composition can affect the mAbs stability in reconstituted solutions for subcutaneous injections. Part I: Contribution of processing stresses against composition.
    Barceló-Chong CM; Filipe V; Nakach M; Ré MI
    Int J Pharm; 2024 Apr; 655():123925. PubMed ID: 38518870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical Characterization of Binary Therapeutic Monoclonal Antibody Mixtures.
    Krieg D; Berner C; Winter G; Svilenov HL
    Mol Pharm; 2020 Aug; 17(8):2971-2986. PubMed ID: 32687367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting monoclonal antibody pharmacokinetics following subcutaneous administration via whole-body physiologically-based modeling.
    Hu S; D'Argenio DZ
    J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):385-409. PubMed ID: 32500362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies.
    Gréa T; Jacquot G; Durand A; Mathieu C; Gasser A; Zhu C; Banerjee M; Hucteau E; Mallard J; Lopez Navarro P; Popescu BV; Thomas E; Kryza D; Sidi-Boumedine J; Ferrauto G; Gianolio E; Fleith G; Combet J; Brun S; Erb S; Cianferani S; Charbonnière LJ; Fellmann L; Mirjolet C; David L; Tillement O; Lux F; Harlepp S; Pivot X; Detappe A
    Adv Mater; 2024 Mar; 36(13):e2308738. PubMed ID: 38105299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.